(Q33965325)

30 July 2017

title

Treatment of lithium-induced diabetes insipidus with amiloride (English)

1 reference

30 July 2017

1 reference

1 reference

Christopher K Finch

1

1 reference

30 July 2017

Kristi W Kelley

series ordinal

2

1 reference

30 July 2017

Raela B Williams

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

30 July 2017

1 reference

30 July 2017

volume

23

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

546-550

1 reference

Lithium-induced diabetes insipidus-like syndrome

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.4.546.32121

Lithium-induced nephrogenic diabetes insipidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.4.546.32121

Drug-induced diabetes insipidus: incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.4.546.32121

Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.4.546.32121

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.4.546.32121

Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.4.546.32121

Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.4.546.32121

Treatment of severe lithium-induced polyuria with amiloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.4.546.32121

Nephrogenic diabetes insipidus persisting 57 months after cessation of lithium carbonate therapy: report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.4.546.32121

Effects of the GABAergic agent sodium valproate on the arginine vasopressin responses to hypertonic stimulation and upright posture in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.4.546.32121

10.1592/PHCO.23.4.546.32121

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference